SurveyVitals Unveils New Question Bank Feature
BOISE, Idaho, July 9, 2021 /PRNewswire/ -- SurveyVitals, Inc., a patient experience analytics platform, today announced the release of its groundbreaking,...
Month: July 2021
Jupiter Wellness Licenses Photocil(TM), a Novel Topical Treatment of Psoriasis, Vitiligo, Pruritis and Atopic Dermatitis
*Photo-Therapy in a tubeJUPITER, FL / ACCESSWIRE / July 9, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced they have...
NLS Pharmaceutics to Present at the Access to Giving Virtual Investor Conference on July 15th
STANS, SWITZERLAND / ACCESSWIRE / July 9, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
Clover Health Expands Management Team, Appointing Prabhdeep Singh as Chief Growth Officer and Justin Joseph as Chief Strategy & Development Officer
Justin Joseph Chief Strategy & Development Officer Prabhdeep Singh Chief Growth Officer NASHVILLE, Tenn., July 09, 2021 (GLOBE NEWSWIRE) --...
Foghorn Therapeutics to Participate at the William Blair Biotech Focus Conference 2021
CAMBRIDGE, Mass., July 09, 2021 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development...
VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021
SOUTH SAN FRANCISCO, Calif., July 09, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing...
Tauriga Sciences, Inc. and Think BIG, LLC Confirm the Launch of Two Limited-Edition Frank White/Tauri-Gum Versions
07_09_2021 PR Side-by-Side: Retail Boxes Frank White/Tauri-Gum™ NEW YORK, NY, July 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences,...
Innovative MedTech Announces SarahCare Subsidiary Receives Coronavirus Relief Funds from State of Ohio
BLUE ISLAND, Ill., July 09, 2021 (GLOBE NEWSWIRE) -- Innovative MedTech, Inc. (the "Company") (OTC: IMTH), a provider of health and...
Applied Molecular Transport Presents Additional Positive Data from Oral AMT-101 Phase 1b in Ulcerative Colitis at ECCO ‘21 Virtual Congress
Once daily, oral AMT-101 was safe and well tolerated, and demonstrated trends of improvement in objective measures of inflammation: fecal...
Tempest to Participate in William Blair 2021 Biotech Focus Conference
SOUTH SAN FRANCISCO, Calif., July 09, 2021 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing...
ARCA biopharma to Present at Access to Giving Virtual Investor Conference on July 13th
WESTMINSTER, Colo., July 09, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine...
Reneo Pharmaceuticals Announces Partial Waiver of Lock-Up Restriction
SAN DIEGO, July 09, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on...
Genetic Technologies Continues to Break New Ground as it Advances Development of its Predictive Risk Test for Multiple Cancers & Morbidities
MELBOURNE, Australia, July 09, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG, NASDAQ: GENE, "Company", "GTG"), a diversified Genomics...
ORYZON Presents Safety and Efficacy Data of Vafidemstat From the Phase II ESCAPE Trial in Severe COVID-19 Patients at ECCMID-2021
Vafidemstat was safe and well tolerated Confirmed anti-inflammatory activity of vafidemstat Vafidemstat reduced exacerbated CD4+ T cell activation and inflammatory...
Qilian International Holding Group Limited Enters into Investment Agreement for Pig By-product Processing Project in Chongqing
Jiuquan, China, July 09, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical...
Molecular Templates, Inc. Announces Dosing of First Subject in Phase 1 Study of MT-6402 in PD-L1-Positive Solid Tumors
AUSTIN, Texas, July 09, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical...
MediWound Announces Peer-Reviewed Paper Detailing EscharEx Phase 2 Randomized Control Trial Results Published in the Online Wound Repair and Regeneration Journal
Study Findings Demonstrate Strong Results in Debriding Venous Leg Ulcers and Diabetic Foot Ulcers Interim Assessment of Ongoing U.S. Phase...
Galectin Therapeutics Announces Positive Top-Line Results from a Phase 1b Clinical Trial Extension of Belapectin in Combination with KEYTRUDA® in Advanced Metastatic Melanoma and Head and Neck Cancer
Belapectin and KEYTRUDA® combination immunotherapy in patients with treatment-refractory and progressive diseases shows a cancer control rate of 56% in...
Novo Holdings Launches Muna Therapeutics with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases
COPENHAGEN, Denmark, July 9, 2021 /PRNewswire/ -- Novo Holdings, a global life science investor, today announces that it has co-led...
Muna Therapeutics Launches with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases
COPENHAGEN, Denmark, July 9, 2021 /PRNewswire/ -- Muna Therapeutics ("Muna"), pioneering the development of first-in-class small molecule therapeutics for neurodegenerative diseases,...